The Procter & Gamble Company (NYSE:PG) Shares Purchased by Little House Capital LLC

Little House Capital LLC increased its holdings in The Procter & Gamble Company (NYSE:PG) by 37.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,235 shares of the company’s stock after buying an additional 2,776 shares during the quarter. Little House Capital LLC’s holdings in Procter & Gamble were worth $1,773,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of PG. Itau Unibanco Holding S.A. purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at approximately $28,000. Fairway Wealth LLC purchased a new stake in Procter & Gamble during the second quarter worth about $29,000. Ruedi Wealth Management Inc. increased its stake in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after purchasing an additional 77 shares during the period. POM Investment Strategies LLC acquired a new position in shares of Procter & Gamble during the second quarter worth about $34,000. Finally, Quest Partners LLC acquired a new position in shares of Procter & Gamble during the second quarter worth about $36,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the sale, the insider now owns 11,537 shares in the company, valued at approximately $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the transaction, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the transaction, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 383,194 shares of company stock worth $65,140,718 over the last 90 days. 0.17% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on PG. Evercore ISI increased their price objective on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a report on Monday. DA Davidson increased their price objective on Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research note on Monday. Royal Bank of Canada restated a “sector perform” rating and issued a $164.00 price objective on shares of Procter & Gamble in a report on Monday. Morgan Stanley lifted their price objective on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday. Finally, StockNews.com lowered Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Nine equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and an average price target of $177.00.

Procter & Gamble Price Performance

Shares of PG traded down $2.08 during mid-day trading on Monday, reaching $169.20. 2,404,409 shares of the stock traded hands, compared to its average volume of 6,671,717. The firm has a fifty day moving average price of $171.77 and a 200 day moving average price of $167.24. The company has a market cap of $399.33 billion, a price-to-earnings ratio of 27.65, a price-to-earnings-growth ratio of 3.74 and a beta of 0.41. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a 1 year low of $142.50 and a 1 year high of $177.94.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The business had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same period in the previous year, the firm posted $1.83 earnings per share. The firm’s revenue for the quarter was down .6% on a year-over-year basis. As a group, equities research analysts predict that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.38%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio is currently 65.69%.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.